[Biomarkers combined with radiology in early diagnosis of invasive fungal diseases in patients with hematological malignancies]. 2020

E L Jiang, and M Z Han
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.

UI MeSH Term Description Entries
D011871 Radiology A specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072742 Invasive Fungal Infections Mycoses which manifest as infections of deep tissue or blood. Disseminated Fungal Infection,Invasive Mycoses,Disseminated Fungal Infections,Fungal Infection, Disseminated,Fungal Infection, Invasive,Infection, Disseminated Fungal,Infection, Invasive Fungal,Invasive Fungal Infection,Mycoses, Invasive
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D042241 Early Diagnosis Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME. Early Detection of Disease,Diagnosis, Early,Disease Early Detection
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

E L Jiang, and M Z Han
January 2022, [Rinsho ketsueki] The Japanese journal of clinical hematology,
E L Jiang, and M Z Han
April 2024, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
E L Jiang, and M Z Han
September 2013, Zhonghua yi xue za zhi,
E L Jiang, and M Z Han
January 2017, Boletin de la Asociacion Medica de Puerto Rico,
E L Jiang, and M Z Han
March 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!